outcomes following venetoclax monotherapy in patients with r/r wm in the real-world setting
Published 5 months ago • 86 plays • Length 3:03Download video MP4
Download video MP3
Similar videos
-
0:46
prolonging survival in patients with aml ineligible for intensive chemotherapy
-
1:17
the efficacy of olutasidenib in aml following venetoclax failure
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
1:36
cll2-give trial: ibrutinib, venetoclax and obinutuzumab in patients with tp53-mutated cll
-
1:43
six-year update from cll14: fixed-duration venetoclax obinutuzumab for previously untreated cll
-
2:17
outcomes of patients with monocytic aml treated with venetoclax & azacitidine
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:30
the use of targeted drug therapy for aggressive lymphoma
-
19:14
时隔5年我的我终于回了趟国，发现...中西方的差距，越来越大。可我实在是太后悔了！早知道当年就应该。。。
-
4:56
icml 2023 data-efficient contrastive self-supervised learning
-
2:30
real-world outcomes of venetoclax azacitidine versus intensive chemotherapy in newly diagnosed aml
-
1:50
outcomes of patients with dlbcl following asct and/or car-t
-
2:45
the addition of venetoclax to hmas for the treatment of cmml: a retrospective psm analysis
-
0:57
novel therapeutic strategies in all
-
3:17
pet imaging to predict treatment outcomes: follow-up from the echelon-2 trial
-
8:57
outcomes of sct in t-all and t-lbl
-
2:49
the role of the immune system in the pathophysiology of mds
-
1:43
results from a phase ii trial of pirtobrutinib, venetoclax, and obinutuzumab in cll
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:31
clinical outcomes are poor for cll patients treated with venetoclax post-btki exposure
-
3:58
extended follow-up of glofitamab monotherapy in r/r lbcl: durability of cr and likelihood of crs